These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 794647)

  • 1. [Characteristics of "supersound" antigens of Proteus mirabilis].
    Ielshina MO; Omel'ianets' TH; Open'ko LV; Dykhovychna DIe; Lukach IH
    Mikrobiol Zh; 1976; 38(6):756-60. PubMed ID: 794647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enteropathogenicity of Proteus mirabilis bacteria and pathogenesis of experimental intestinal infections caused by them].
    Bidnenko SI; Bernasovskaia EP; Anisimova IuN; Barshteĭn IuA; Mel'nitskaia EV
    Mikrobiol Zh (1978); 1985; 47(6):81-8. PubMed ID: 3917194
    [No Abstract]   [Full Text] [Related]  

  • 3. [An immunochemical analysis of antigenic complexes from proteus, obtained by different methods].
    Omel'ianets TG; Elshina MA; Dykhovichnaia DE; Lukach IG
    Mikrobiol Zh; 1974; 36(6):763-6. PubMed ID: 4614021
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.
    Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O antigens of Proteus mirabilis and Proteus vulgaris strains isolated from patients with bacteremia.
    Larsson P
    J Clin Microbiol; 1980 Oct; 12(4):490-2. PubMed ID: 6999017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative characteristics of Proteus hauseri strains of different origins].
    Elshina MA; Lebed' BA; Open'ko LV; Lukach IG
    Mikrobiol Zh; 1974; 36(1):93-7. PubMed ID: 4840335
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of lysine in the serological specificity of some Proteus mirabilis lipopolysaccharides.
    Gromska W; Kaca W; Kotełko K
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):237. PubMed ID: 86335
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterogeneity of the lipopolysaccharide from Proteus mirabilis O27.
    Krajewska D; Gromska W
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):581-7. PubMed ID: 6751282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological investigations on ribitol-containing lipopolysaccharides from Proteus mirabilis.
    Kotełko K; Zych K
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):233-6. PubMed ID: 86334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Purification of a thermolabile antigen occuring in gram-negative bacteria by means of affinity chromatography (author's transl)].
    Seltmann G; Reissbrodt R
    Z Allg Mikrobiol; 1974; 14(3):237-9. PubMed ID: 4608332
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiological application of a new bacteriocin typing procedure for Proteus mirabilis].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Gálvez Vargas R; Piédrola Angulo G
    Rev Latinoam Microbiol; 1985; 27(1):7-10. PubMed ID: 3892620
    [No Abstract]   [Full Text] [Related]  

  • 12. [The genus Proteus. Pathogenic and epidemiologic aspects].
    Gómez A; Baquero F; Nombela C
    Enferm Infecc Microbiol Clin; 1991; 9(7):425-32. PubMed ID: 1799614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sensitivity of Proteus mirabilis strains to the bactericidal action of human serum].
    Frolov AF; Parkhomenko LV; Lukach IG
    Mikrobiol Zh (1978); 1986; 48(3):23-6. PubMed ID: 3077431
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigens common to human and bacterial cells., 3. Autoagglutinin to blood group A stimulated by sepsis due to Proteus mirabilis.
    Drach GW; Reed WP; Williams RC
    J Lab Clin Med; 1973 Jun; 81(6):919-24. PubMed ID: 4122859
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental study of the protective activity of Proteus antigenic complexes per se and in association with various staphylococcal vaccines].
    Kaverina KG; Kreĭnin LS; Egorova NB; Efremova VN; Shuvaeva LP
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Aug; (8):73-7. PubMed ID: 386659
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic and immunogenic activity of flagella and fimbriae preparations from uropathogenic Proteus mirabilis.
    Legnani-Fajardo C; Zunino P; Algorta G; Laborde HF
    Can J Microbiol; 1991 Apr; 37(4):325-8. PubMed ID: 1680542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific immune preparations for the prevention and treatment of suppurative-inflammatory diseases of Proteus etiology (a review of the literature)].
    Nazarchuk LV
    Lik Sprava; 1992 Jun; (6):28-34. PubMed ID: 1280887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serological activity of different antigenic preparations of Proteus in precipitation tests].
    Omel'ianets' TG; Elshina MO; Open'ko LV; Dikhovichna DE; Lukch IG
    Mikrobiol Zh; 1975; 37(4):482-6. PubMed ID: 55948
    [No Abstract]   [Full Text] [Related]  

  • 19. [Structure of an O-specific polysaccharide of Proteus mirabilis 03, containing N-(2-hydroxyethyl)-D-alanine].
    Vinogradov EV; KatsaV ; Shashkov AS; Petrashik D; Rozhal'ski A; Knirel' IuA; Kochetkov NF
    Bioorg Khim; 1989 Oct; 15(10):1431-4. PubMed ID: 2483615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serological diagnosis and immunological aspects of Proteus infection. V. Design and trial of polyvalent antigenic preparations].
    Bidnenko SI; Mel'nitskaia EV; Rudenko AV; Nazarchuk LV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):49-53. PubMed ID: 3887814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.